Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
First Claim
Patent Images
19. A nasal solution, comprising:
- a) water, b) sodium chloride, 0.65 % by weight, c) pyruvate, at least 0.1 mM, d) buffer, and optionally e) a preservative. wherein the nasal moisturizing saline solution is buffered and made isotonic.
1 Assignment
0 Petitions
Accused Products
Abstract
A method for treating the disease state in mammals caused by mammalian nasal and sinus cells involved in the inflammatory response is disclosed. Mammalian nasal and sinus cells participating in the inflammatory response are contacted with an inflammatory response mediator which reduces the undesired inflammatory response and is an antioxidant. The inflammatory response mediator may further provide a cellular energy source and be a building block in the cellular synthesis of other cellular components. Compositions for reducing and treating undesired inflammatory response are also disclosed.
-
Citations
30 Claims
-
19. A nasal solution, comprising:
-
a) water, b) sodium chloride, 0.65 % by weight, c) pyruvate, at least 0.1 mM, d) buffer, and optionally e) a preservative. wherein the nasal moisturizing saline solution is buffered and made isotonic. - View Dependent Claims (20, 21, 22, 23, 24, 25)
-
-
27. A method for the prevention and/or treatment of rhinitis, eosinophilia syndrome, sinusitis and related conditions associated with nasal congestion, comprising administering a nasal solution to the nostrils of a patient in need thereof, wherein the nasal moisturizing saline solution comprises:
-
a) water, b) sodium chloride, 0.65% by weight, c) pyruvate, at least 0.1 mM, d) buffer, and optionally e) a preservative. wherein the nasal moisturizing saline solution is buffered and made isotonic. - View Dependent Claims (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 26, 28, 29, 30)
-
-
29-1. The method of claim 27, wherein the preservative is selected from the group consisting of phenylcarbinol, benzalkonium chloride, and thimerosal.
Specification